| Booming Clinical Trials Market in India |
Jan, 2009 | Pages : 105 | Price : US$ 1200.00 |
|
| |
| Booming Global Obesity Drug Market |
Dec, 2008 | Pages : 80 | Price : US$ 1100.00 |
| By 2012, it’s expected that more than two billion people will be overweight and 600 Million will be obese, representing immense opportunities for both the markets. |
| |
| Ukraine Pharma - New Opportunities for Growth |
Nov, 2008 | Pages : 60 | Price : US$ 800.00 |
| The Ukraine market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012, despite country’s unstable political environment. |
| |
| Global Pharmaceutical Market Forecast to 2012 |
Oct, 2008 | Pages : 165 | Price : US$ 1800.00 |
| Growing at a CAGR of around 8%, the global pharmaceutical market is forecasted to reach US$ 1043.4 Billion in 2012. North America remains the largest pharmaceutical market. |
| |
| Russian Pharma Sector Analysis |
Sep, 2008 | Pages : 115 | Price : US$ 1100.00 |
| The Russian pharmaceutical market grew 16% in 2007 as compared to 2006. The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012. |
| |
| Booming Pharma Sector in India |
Aug, 2008 | Pages : 100 | Price : US$ 1100.00 |
| Traditional branded generics presently dominate the Indian pharmaceutical market. Between 2007-08 and 2011-12, the Indian pharma market is expected to grow at a CAGR of nearly 16%. |
| |
| Global Cancer Treatment Forecast to 2012 |
Aug, 2008 | Pages : 85 | Price : US$ 1600.00 |
| Growing at a CAGR of 12.3% between 2007 and 2012, the global market for cancer drugs is expected to cross US$ 78 Billion by 2012. |
| |
| Emerging Pharmaceutical Markets Globally |
Apr, 2008 | Pages : 125 | Price : US$ 1500.00 |
| The E7 Pharmaceutical markets are expected to grow at a CAGR 11.5% (2007-2012) reaching US$ 116 Billion. Cardiovascular, cancer and other diseases have taken over communicable diseases. |
| |
| Indian Contract Manufacturing - A Hot Opportunity |
Mar, 2008 | Pages : 70 | Price : US$ 1400.00 |
| Indian contract manufacturing market is expected to grow in excess of CAGR 37% between 2007 and 2012. Most companies presently outsource APIs and intermediates from India. |
| |
| Indian Pharma Sector Analysis |
Jan, 2008 | Pages : 100 | Price : US$ 0.00 |
| Around 67 Million Indians are expected to be above 67 years of age by 2011. This age group spends around 3 to 4 times more on drugs than those in younger age groups, thus fuelling the market growth. |
| |
|
|
